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Polymorphonuclear leukocytes (PMNs) are a central part of the human innate
immunity and they are dominating the response against bacterial infections in
the cystic ﬁbrosis (CF) lung. However, the opportunistic pathogen Pseudomonas
aeruginosa can evade destruction by PMNs and may thus cause persistent infections
in immuno-compromised patients. In the present in vitro study, interactions between
P. aeruginosa (in the sessile and planktonic modes of growth) and PMNs were
analyzed by means of DNA microarray based transcriptomics. We found that the
P. aeruginosa wild type bioﬁlms, in contrast to planktonic cultures and quorum
sensing (QS) deﬁcient strains, respond to PMN exposure in a rather aggressive
manner. The response does not involve protective mechanisms such as those
involved in oxidative stress. Rather it is dominated by an up-regulation of QS
controlled virulence determinants such as those encoded by pqs, phz, rhlAB, lecB
and lasB, all of which are able to cripple and eliminate eukaryotic cells. Our data
supports a model by which P. aeruginosa recognizes the presence of PMN’s and
channels this information through the QS system. Consequently, it strengthens
the view that QS plays a key role in P. aeruginosa recognition and evasion of
components of the host defense.
206 Defective CFTR Cl− channel enhances proteasomal degradation
and reduces NF-úB activity in lung epithelial cells exposed to
oxidative stress
E. Boncoeur1, T. Roque1, E. Bonvin1, V. Saint Criq1, M. Bonora1, A. Clement1,
O. Tabary1, J. Jacquot1. 1Inserm UMR-S 719, Hoˆpital St-Antoine, UPMC-Paris6,
Paris, France
Background: In CF patients, the loss of functional cystic ﬁbrosis (CF) transmem-
brane conductance regulator (CFTR) protein in lung epithelial cells leads to reduced
volume and increased oxidation of the airway surface liquid.
Objective: In this study, we evaluated the role of CFTR Cl− channel activity in
the control of ubiquitin-proteasome activity and NF-úB/IúB-a signaling in lung
epithelial cells exposed to oxidative stress.
Methods: We exposed mice for 64-h to hyperoxia-mediated oxidative stress and
CF or non-CF bronchial epithelial cells during 24 h.
Results: After oxidative stress, CFTR deﬁcient mice exhibited an absence of
degradation of NF-úB inhibitor (IúB-a) compared to CFTR+/+ animals. This
result was accompanied by a signiﬁcantly higher lung proteasomal activity. After
oxidative stress, human CFTR-deﬁcient bronchial epithelial cells exhibited higher
proteasomal activity and a lack of increased NF-úB-dependent transcriptional
activity compared to CFTR-sufﬁcient lung epithelial cells. In response to oxidative
stress, degradation of NF-úB inhibitor IúB-a was defective in two CFTR deﬁcient
lung models. Moreover, the inhibition of CFTR Cl− channel activity in normal
bronchial immortalized cell line 16HBE14o- by a speciﬁc CFTRinh−172 inhibitor
exposed to oxidative stress, caused a signiﬁcant increase of proteasomal degradation
activity.
Conclusion: All together, our data show that functional CFTR Cl− channel activity
is crucial in regulating lung proteasomal degradation and NF-úB activity in
conditions of oxidative stress.
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Cystic ﬁbrosis is a severe inﬂammatory disease characterized by a massive re-
cruitment of neutrophils to the lungs. Gap junctions may serve as a conducting
pathway to enhance such recruitment and spread inﬂammation within the lung
alveoli. Indeed, we found that intratracheal instillation of 43Gap26, a blocking
peptide of the gap junction protein connexin43 (Cx43), reduced inﬂammation by
70% in a mouse model subjected to intratracheal instillation of Pseudomonas
aeruginosa LPS. In comparison to wild type animals, mice heterozygous for the
Cx43 gene exhibited a lower inﬂammatory response, representing a 54% protection
to inﬂammation. In contrast, an exaggerated inﬂammatory response characterized
with a massive neutrophil recruitment was observed in a mouse model expressing
a non regulatable mutant of Cx43. Finally, Cx43 expression was unaffected in mice
protected from LPS-induced inﬂammation by inactivation of either the TNF-alpha
gene or the protein. Together, our ﬁndings indicate that functional expression of
Cx43 in lungs is activated by mediators of the inﬂammatory cascade and that
this regulation modulates in turn the recruitment of neutrophils and therefore the
intensity of lung inﬂammation. This reveals a pro-inﬂammatory role of Cx43, which
may represent a pharmacological target to modulate the severity of lung diseases
such as cystic ﬁbrosis.
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Immunosuppressive effects of vitamin (vit.) D and a potential role of vitamin D
deﬁciency in the pathophysiology of autoimmune diseases have been described. We
investigated if vitamin D deﬁciency could contribute to the chronic proinﬂamma-
tory state and the higher occurrence of immune-hyperreactivity-related conditions
in CF patients.
Methods: Cross-sectionally determined vit.D variables were compared to lung
function, inﬂammatory parameters and immune hyperreactivity markers in 898 CF
patients by multiple linear regression analysis. Vit.D intake was based on a 7-day
dietary food record.
Findings: Blood vit.D positively correlated with FEV1 (p< 0.01) as well as
with FVC (p< 0.01). Negative correlation was found between blood vit.D and
IgG (p< 0.001), supplemented vit.D per kg BW and IgG (p< 0.001), total vit.D
intake per kg BW and IgG (p< 0.05). Additionally, lower blood vitamin D levels
were related to both presence of pathological OGTT (p< 0.05) and occurrence
of CFRD (p< 0.05). Correspondingly, total vitamin D intake (p< 0.01) and total
vitamin D intake per kg BW (p< 0.01) correlated negatively with HbA1C values.
In children (n = 442) blood vitamin D correlated negatively with transglutaminase
levels (p< 0.05). Average vitamin D concentrations did not correlate with the
antiinﬂammatory cytokine IL-10 in a limited series.
Conclusion: Vitamin D deﬁciency might contribute to the continuous shift towards
inﬂammation as well as to the higher prevalence of DM and celiac disease in
CF patients. New recommendations for vitamin D supplementation and monitoring
of blood vitamin D levels are needed.
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